These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35946099)

  • 1. In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
    Maes M; Andrés-Rodríguez L; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
    CNS Neurol Disord Drug Targets; 2023; 22(2):215-225. PubMed ID: 35946099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia.
    Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
    Mol Neurobiol; 2019 Oct; 56(10):7056-7073. PubMed ID: 30972627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
    Kanchanatawan B; Sriswasdi S; Maes M
    Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates.
    Mousa RF; Al-Hakeim HK; Alhaideri A; Maes M
    Metab Brain Dis; 2021 Jan; 36(1):169-183. PubMed ID: 32965599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In major dysmood disorder, physiosomatic, chronic fatigue and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity.
    Maes M; Almulla AF; Zhou B; Algon AAA; Sodsai P
    Sci Rep; 2024 Mar; 14(1):7344. PubMed ID: 38538641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.
    Kanchanatawan B; Sirivichayakul S; Thika S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Noto C; Ivanova R; Maes M
    Metab Brain Dis; 2017 Aug; 32(4):1003-1016. PubMed ID: 28258445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.
    Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
    Neurotox Res; 2019 Aug; 36(2):306-322. PubMed ID: 31077000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways.
    Almulla AF; Al-Hakeim HK; Abed MS; Carvalho AF; Maes M
    Schizophr Res; 2020 Aug; 222():342-353. PubMed ID: 32467068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
    Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    Mol Neurobiol; 2017 May; 54(4):3038-3049. PubMed ID: 27037573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    Metab Brain Dis; 2017 Oct; 32(5):1571-1583. PubMed ID: 28600633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
    Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
    Maes M; Leunis JC
    Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways.
    Maes M; Vojdani A; Geffard M; Moreira EG; Barbosa DS; Michelin AP; Semeão LO; Sirivichayakul S; Kanchanatawan B
    Biomol Concepts; 2019 Nov; 10(1):209-225. PubMed ID: 31734647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease.
    Asad HN; Al-Hakeim HK; Moustafa SR; Maes M
    CNS Neurol Disord Drug Targets; 2023; 22(2):191-206. PubMed ID: 35366785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.
    Maes M; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
    Mol Neurobiol; 2021 Jul; 58(7):3319-3334. PubMed ID: 33675500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia.
    Maes M; Vojdani A; Galecki P; Kanchanatawan B
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32957709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    CNS Neurol Disord Drug Targets; 2017; 16(4):472-483. PubMed ID: 28403801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum agrin and talin are increased in major depression while agrin and creatine phosphokinase are associated with chronic fatigue and fibromyalgia symptoms in depression.
    Al-Hakeim HK; Al-Issa AAR; Maes M
    Metab Brain Dis; 2020 Jan; 35(1):225-235. PubMed ID: 31734845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
    Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.